Renalogic

Renalogic is a pioneering company in the healthcare industry, specializing in managing risks associated with dialysis and Chronic Kidney Disease (CKD). Founded in 2002 and headquartered in the United States, Renalogic offers a range of services including cost containment, data analysis and risk stratification, CKD management, and member education. The company's mission to revolutionize the industry has made it a leader in renal risk analytics, management, and dialysis cost containment. Renalogic's professional team comprises experts in healthcare administration, case management, clinical renal disease, legal specialists, and negotiation, ensuring an end-to-end solution for identifying and managing the risk of renal disease in member populations. Renalogic's services, such as cost containment and CKD management, are tailored to each member and have a proven track record, with over 14 years of successful dialysis cost containment services. The company also offers comprehensive data-driven approaches to predict and prevent chronic conditions associated with CKD and dialysis. Furthermore, Renalogic provides patient-centered care management services aimed at improving members' quality of care while reducing their overall medical spend. Educational services are also available to provide critical information on managing CKD, Medicare options, and dialysis modalities. The company recently secured a Venture Round investment on 03 March 2021, with Carrick Capital Partners as the investing firm. Renalogic's commitment to revolutionize renal risk management and dialysis cost containment positions it as a promising entity with potential for impactful growth and innovation in the healthcare industry. For more information, Renalogic can be reached at 866-265-1719 or via e-mail at [email protected].